Why is Venmax Drugs falling/rising?

As of 22-Sep, Venmax Drugs & Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs 25.10, which reflects a decrease of Rs 1.3 or 4.92%. The stock has underperformed its sector by 3.84% today and has opened with a loss of 2.5%. It has touched an intraday low of Rs 25.1, indicating a downward trend after two consecutive days of gains. Over the past week, the stock has decreased by 3.65%, and over the past month, it has fallen by 20.57%. Although the stock is currently above its 200-day moving average, it is below its 5-day, 20-day, 50-day, and 100-day moving averages. There has been a notable increase in investor participation, with delivery volume rising by 75.09% against the 5-day average, suggesting some interest despite the price drop.
In the broader market context, the Sensex has shown a positive return of 0.46% over the past week, contrasting with Venmax's negative performance. This indicates that the stock is not only declining in value but also lagging behind the overall market trend. Year-to-date, Venmax has outperformed the benchmark with a return of 39.14% compared to the Sensex's 5.15%, but the recent downturn suggests a potential shift in investor sentiment or market conditions affecting the stock negatively. The absence of specific positive or negative factors in the dashboard limits the understanding of the underlying reasons for the stock's recent movement.